6-Month Buy/Sell Trend
Buys
Sells
▶
2026-03-24
▼ 3 sells
· $12K
⚡ 3 insiders
▶
2026-03-25
▼ 1 sell
· $$602
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Smalling Ralph | Head of Regulatory | ▼ Sell | 240 | $3 | $602 | Mar 26 |
▶
2026-03-02
▼ 1 sell
· $29K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Thomas John | — | ▼ Sell | 10,000 | $3 | $29K | Plan | Mar 3 |
▶
2026-01-02
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Litten Jason | Chief Medical Officer | A | 275,000 | $0 | $0 | Jan 7 |
▶
2025-08-21
▼ 5 sells
· $66K
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Cappello Joseph | Chief Technical Officer | ▼ Sell | 1,270 | $3 | $4K | Dec 11 | |
| Cappello Joseph | Chief Technical Officer | ▼ Sell | 1,463 | $3 | $5K | Dec 11 | |
| Yu Yong | SVP, Clinical Development | ▼ Sell | 3,219 | $3 | $11K | Dec 11 | |
| Zindrick Thomas | President and CEO | ▼ Sell | 12,673 | $3 | $42K | Dec 11 | |
| Smalling Ralph | Head of Regulatory | ▼ Sell | 1,244 | $3 | $4K | Dec 9 |
▶
2025-11-17
▼ 4 sells
· $37K
⚡ 4 insiders
▶
2025-09-03
▼ 1 sell
· $2K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Smalling Ralph | Head of Regulatory | ▼ Sell | 580 | $3 | $2K | Dec 9 |
▶
2025-12-05
▼ 1 sell
· $$774
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Smalling Ralph | Head of Regulatory | ▼ Sell | 165 | $5 | $774 | Dec 9 |
▶
2025-12-01
▼ 1 sell
· $50K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Thomas John | — | ▼ Sell | 10,000 | $5 | $50K | Plan | Dec 2 |
▶
2025-09-01
23 other
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Cappello Joseph | Chief Technical Officer | D | 16,666 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | A | 16,666 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | D | 80,000 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | A | 80,000 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | D | 13,333 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | A | 13,333 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | D | 65,000 | — | — | Sep 3 | |
| Cappello Joseph | Chief Technical Officer | A | 65,000 | — | — | Sep 3 | |
| Smalling Ralph | Head of Regulatory | A | 10,000 | $0 | $0 | Sep 3 | |
| Smalling Ralph | Head of Regulatory | D | 8,333 | — | — | Sep 3 | |
| Smalling Ralph | Head of Regulatory | A | 8,333 | — | — | Sep 3 | |
| Yu Yong | SVP, Clinical Development | D | 207,652 | — | — | Sep 3 | |
| Yu Yong | SVP, Clinical Development | A | 207,652 | — | — | Sep 3 | |
| Yu Yong | SVP, Clinical Development | D | 65,000 | — | — | Sep 3 | |
| Yu Yong | SVP, Clinical Development | A | 65,000 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | D | 925,000 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | A | 925,000 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | D | 157,372 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | A | 157,372 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | D | 23,568 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | A | 23,568 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | D | 250,000 | — | — | Sep 3 | |
| Zindrick Thomas | President and CEO | A | 250,000 | — | — | Sep 3 |
▶
2025-08-27
16 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Cappello Joseph | Chief Technical Officer | A | 107,500 | $0 | $0 | Aug 29 | |
| Cappello Joseph | Chief Technical Officer | A | 142,500 | $0 | $0 | Aug 29 | |
| Smalling Ralph | Head of Regulatory | A | 26,230 | $0 | $0 | Aug 29 | |
| Smalling Ralph | Head of Regulatory | A | 34,770 | $0 | $0 | Aug 29 | |
| Yu Yong | SVP, Clinical Development | A | 101,480 | $0 | $0 | Aug 29 | |
| Yu Yong | SVP, Clinical Development | A | 134,520 | $0 | $0 | Aug 29 | |
| Zindrick Thomas | President and CEO | A | 361,200 | $0 | $0 | Aug 29 | |
| Zindrick Thomas | President and CEO | A | 478,800 | $0 | $0 | Aug 29 | |
| Thomas John | — | A | 22,283 | $0 | $0 | Aug 29 | |
| Thomas John | — | A | 28,576 | $0 | $0 | Aug 29 | |
| Mirabelli Mary | — | A | 22,283 | $0 | $0 | Aug 29 | |
| Mirabelli Mary | — | A | 28,576 | $0 | $0 | Aug 29 | |
| Smither John W | — | A | 22,283 | $0 | $0 | Aug 29 | |
| Smither John W | — | A | 28,576 | $0 | $0 | Aug 29 | |
| Tyree James L | — | A | 22,283 | $0 | $0 | Aug 29 | |
| Tyree James L | — | A | 28,576 | $0 | $0 | Aug 29 |
▶
2025-07-01
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Groen Eric | General Counsel & Secretary | A | 270,000 | $0 | $0 | Jul 2 |
▶
2025-06-06
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Thomas John | — | G | 25,000 | $0 | $0 | Jun 24 |
▶
2025-05-12
▼ 5 sells
· $78K
⚡ 5 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Cappello Joseph | VP, Pharmaceutical Development | ▼ Sell | 4,737 | $3 | $14K | May 13 | |
| Smalling Ralph | Head of Regulatory | ▼ Sell | 1,259 | $3 | $4K | May 13 | |
| Yu Yong | VP, Clinical Trial Operations | ▼ Sell | 5,579 | $3 | $16K | May 13 | |
| Zindrick Thomas | President and CEO | ▼ Sell | 10,764 | $3 | $31K | May 13 | |
| Ryder Sean | General Counsel | ▼ Sell | 4,475 | $3 | $13K | May 13 |